SUBSCRIBE
SUBSCRIBE

ADARx Pharmaceuticals Inc.

NEWS
Drug Development
ImmPACT Bio Gains $111M, a New Leader and Positive Trial Results
ImmPACT Bio provided an optimistic update on a Phase I clinical study evaluating its CD19-CD20 bi-specific Chimeric Antigen Receptor T-cell (CAR-T) therapy.
January 20, 2022
 · 
3 min read
 · 
Hayley Shasteen
Business
Money on the Move: September 8 – 14
Ramping up after the Labor Day holiday, funds are flowing fast and free into these life science companies.
September 15, 2021
 · 
5 min read
 · 
Kate Goodwin
JOBS
IN THE PRESS
Press Releases
ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer
July 30, 2024
 · 
3 min read
Business
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
April 2, 2024
 · 
3 min read
Biotech Beach
ADARx Pharmaceuticals to Participate in the 44th Annual Cowen Healthcare Conference
February 21, 2024
 · 
1 min read
Biotech Beach
ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference
January 3, 2024
 · 
1 min read
Biotech Beach
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
August 9, 2023
 · 
3 min read
Drug Development
ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324
January 20, 2023
 · 
2 min read
Biotech Beach
ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
January 20, 2023
 · 
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as Chief Scientific Officer
January 9, 2023
 · 
2 min read
Business
ADARx Pharmaceuticals Further Expands Leadership Team, Appointing Feriandas Greblikas, M.D. as VP of Clinical Development
October 18, 2022
 · 
2 min read
Business
ADARx Pharmaceuticals Expands Leadership Team, Appointing Christopher Prentiss as CFO
September 28, 2022
 · 
2 min read
Load More